I couldn't find the article on Sanofi's website under press releases as was noted by Ramsay Schrum last November however it does appear that it may be back on the table for advancement into Phase 3. Since it's a subsidiary of Sanofi doing the R&D, it may not be getting too much attention at the moment. It would be a nice shot in the arm if Sanofi does advance it showing Zalicus' success with its partners.
You wouldn't happen to be Ramsay, would you? If so, then you aren't the Daug that everyone is referring to.....i.e Stocklaser. Also, I'm a bit curious about Targacept. It seems they have more cash in the till than I thought and a nice low float to play on. I also like the institutional interest in the stock. It's a option traders dream.....lol